Adaptimmune CEO Noble to retire, CFO Rawcliffe steps up to the plate
After a global search, Adaptimmune has found its next CEO at home: Chief Financial Officer Adrian Rawcliffe will
Name: James Noble
Country: UK
Company: Adaptimmune Therapeutics plc
Position: CEO
Reason: Retired
Replaced By: Adrian Rawcliffe
Announcement Date: June 26, 2019, 10:00pm
Resignation Date: June 26, 2019, 10:00pm
